How to Read a Peptide Certificate of Analysis (COA)

What is a peptide Certificate of Analysis?

A COA is a summary of analytical work carried out on a submitted sample. Depending on the scope of testing, it may include chromatographic purity, molecular-mass information, peptide content, water content, residual solvents, endotoxin or other measurements.

The report is only meaningful when its details can be connected to the material being evaluated. A polished document with no batch number, sample identifier or laboratory information provides very little traceability.

Analytical guidance such as ICH Q2(R2) treats identity, purity, impurities and assay as different measured attributes. That distinction is helpful when reviewing any peptide test report.

The quick COA check

Before studying graphs or technical values, check these five basics:

1. Material: Does the compound name match the product?
2. Batch: Does the report batch or lot match the label or product record?
3. Laboratory: Is the testing organisation named and independently contactable?
4. Dates: Does the report show when the sample was received, analysed or reported?
5. Methods: Does it state which test produced each result?

If these details are missing, a purity percentage alone should not be treated as sufficient documentation.

1. Check the batch and sample details

Start with the identifiers at the top of the report. Look for the compound name, sample description, batch or lot number, internal report number and any customer or submitter name.

A report for an older batch may still be scientifically valid for the sample that was tested, but it does not automatically describe a newer batch. Always check whether the report is marked as current or archived.

2. Check the testing laboratory and verification route

The report should name the laboratory and provide enough information to confirm that it exists independently of the seller. Useful details can include a report number, verification code, QR code, digital signature or direct laboratory verification page.

When reviewing the laboratory information, ask:

• Can the laboratory be found through its own website and contact information?
• Can the report number or verification key be checked independently?
• Does the report state whether the laboratory received a sealed unit or a transferred sample?
• Are the analytical methods and instruments identified?
• Does the report include authorised review or approval details?

Independent testing adds separation between the seller and the analytical result. It does not remove the need to check sampling, batch matching and method suitability.

3. How to read an HPLC purity result

High-performance liquid chromatography (HPLC) separates components of a sample as they move through a chromatographic column. A detector records the separated components as peaks on a chromatogram.

A typical HPLC section may show:

• A chromatogram with one main peak and smaller secondary peaks
• The retention time for each detected peak
• Integrated peak areas
• A reported area percentage or purity result
• Basic method conditions such as column, mobile phase, gradient and wavelength

What does an HPLC percentage mean?

A reported HPLC area percentage normally describes how much of the detected chromatographic peak area belongs to the main peak under the stated method. It is a method-dependent result. It should not automatically be read as “this percentage of the vial is active peptide by total mass.”

Substances that are not detected under the chosen conditions may not contribute to the reported area percentage. Water, counter-ions and some residual materials can require different measurements. Co-eluting impurities may also be difficult to distinguish if the method does not adequately separate them.

Questions to ask about the HPLC section

• Is the main peak clearly separated from nearby peaks?
• Are the method and detector conditions stated?
• Is the result labelled as area purity, assay or another measurement?
• Are acceptance criteria shown, and who established them?
• Is there evidence that the method is suitable for its stated purpose?

The FDA laboratory-controls guidance notes that results from an unvalidated method carry greater uncertainty than results from a validated method. A COA should therefore be evaluated as both a result and a description of how that result was produced.

4. How to read a mass spectrometry result

Mass spectrometry (MS) measures ions according to their mass-to-charge ratio. For peptide analysis, the observed ion pattern can be compared with the expected molecular mass or calculated ion series.

A useful MS section may include:

• The expected molecular mass
• The observed mass or mass-to-charge peaks
• The ionisation method, such as electrospray ionisation
• The instrument or analytical method
• A conclusion stating whether the result is consistent with the expected identity

A mass result that agrees with the expected value supports identity, but it is not the same as a complete sequence determination and does not by itself quantify chromatographic purity. Closely related variants, modifications or impurities may require additional separation and analysis.

FDA guidance on specifications explains why identity should not rely only on a single chromatographic retention time and describes combined approaches such as HPLC with mass spectrometry. The principle is useful here: one method can support another because they answer different analytical questions.

5. Purity is not the same as assay or peptide content

This is one of the most important distinctions on a COA. A sample can show a high chromatographic area purity while the measured quantity of peptide in the container differs from the nominal amount.

A strong report labels these measurements clearly rather than presenting every number under the single word “purity.” Research on synthetic peptide reference standards likewise uses multiple analytical techniques to evaluate identity, purity and strength rather than treating them as interchangeable.

6. Other tests that may appear on a peptide COA

The appropriate test set depends on the material and intended laboratory application. A report may also include:

• Water content: measurement of water present in the sample.
• Residual solvents: evaluation of solvents that may remain from synthesis or processing.
• Counter-ion content: measurement of associated ions such as acetate or trifluoroacetate.
• Elemental impurities: testing for selected metals or other elements.
• Bioburden or microbial limits: microbiological measurements under a stated method.
• Endotoxin: a separate test with its own units, limit and method.
• Sterility: a specific microbiological test; it cannot be inferred from HPLC or MS.

The absence of one of these tests does not automatically make a chemical identity or purity result invalid. It means the unperformed test question has not been answered by that COA.

7. Common COA warning signs

Take additional care when a report has one or more of these features:

• No batch, lot or unique sample identifier
• A batch number that does not match the product label
• No named laboratory or independent contact route
• No report date or an old report presented as current
• A result with no stated analytical method
• Only a summary percentage with no supporting data
• A cropped report that removes identification or authorisation details
• A verification link or QR code that does not work
• HPLC purity described as proof of identity, content, sterility and safety
• The same report reused across unrelated batches or product strengths

8. What a COA cannot establish by itself

A COA documents the tests performed on a sample. It does not independently prove every part of the supply chain. In particular, the report cannot by itself confirm that:

• The tested sample was representative of every unit in the batch
• The product offered today comes from the tested batch
• The material remained unchanged after testing, storage and transport
• An untested attribute meets any particular requirement
• The material is suitable for human, veterinary, clinical or diagnostic use

That is why a COA should be considered alongside the product label, batch record, storage information, chain of custody and supplier documentation.

Ten-point peptide COA review checklist

1. Confirm the compound name and material description.
2. Match the batch or lot number to the product record.
3. Check the sample, report and laboratory identifiers.
4. Review receipt, analysis and report dates.
5. Verify the report through the laboratory where possible.
6. Read the analytical method attached to each result.
7. Treat HPLC purity, identity and content as separate measurements.
8. Review chromatograms, spectra and supporting data—not only the headline percentage.
9. Check which attributes were not tested.
10. Confirm that the COA is current for the batch being evaluated.

Review current product documentation

Peptide Products brings available test reports and product-quality information together on the quality information page. Test-report availability varies by product line, so check the relevant product and batch before ordering.

You can also browse the research catalogue or contact support with a product, batch or documentation question.

References and further reading

1. International Council for Harmonisation. ICH Q2(R2): Validation of Analytical Procedures .
2. U.S. Food and Drug Administration. Analytical Procedures and Methods Validation for Drugs and Biologics .
3. U.S. Food and Drug Administration. Q6A Specifications: Test Procedures and Acceptance Criteria .
4. McCarthy D, Han Y, Carrick K, et al. Reference Standards to Support Quality of Synthetic Peptide Therapeutics .
5. National Institute of Standards and Technology. Tandem Mass Spectral Library .